Molecular Partners AG is a Switzerland-based clinical-stage biotech company developing DARPin (Designed Ankyrin Repeat Proteins) a new class of custom-built protein therapeutics based on natural binding proteins that open a new dimension of multi-functionality and multi-target specificity in drug design. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.
Código da empresaMOLN
Nome da EmpresaMolecular Partners AG
Data de listagemOct 22, 2014
CEODr. Patrick Amstutz, Ph.D.
Número de funcionários159
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 22
EndereçoWagistrasse 14
CidadeSCHLIEREN
Bolsa de valoresSIX Swiss Exchange
PaísSwitzerland
Código postal8952
Telefone41447557700
Sitehttps://www.molecularpartners.com/
Código da empresaMOLN
Data de listagemOct 22, 2014
CEODr. Patrick Amstutz, Ph.D.
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.

Sem dados